Sign In

Adrian Chung, MBA, CA

Genomics | Precision Medicine | Product | Strategy | Ex-Deloitte, ThermoFisher

Adrian Chung, MBA, CA, is an expert in genomics and molecular technologies, with a passion for advancing human health through innovative products.

With a background in management consulting, finance, and leadership roles in product management, strategy, and marketing, Adrian possesses a diverse skill set applicable to product development and organizational transformation.

Adrian excels in identifying early value drivers, collaborating with domain experts, and leading cross-functional teams to drive informed decisions in product lifecycle management.

Currently focusing on the convergence of genomics and AI, Adrian leverages machine learning to revolutionize cancer detection and treatment.

Adrian holds a BSc in Human Genetics from University College London, an MBA from Kellogg School of Management, and is a Chartered Accountant and Chartered Financial Analyst Level I.

Having worked with renowned clients like Illumina, Pfizer, and Cisco, Adrian is open to opportunities in product, marketing, and strategy within genomics, cellular analysis, and the intersection of life sciences and technology.

His key interests include product management, corporate strategy, genomics, molecular biology, AI, and machine learning.

Adrian has held leadership positions at DELFI Diagnostics, Visby Medical, Thermo Fisher Scientific, Viacom, and Deloitte Consulting, covering areas like product management, corporate strategy, marketing, and business development.

Highlights

May 10 · linkedin

It's not often you get the opportunity to take an emerging genomic technology and bring it to patients to create meaningful impact. To that, I'm excited to be joining as Director of Product Management at DELFI Diagnostics where I'll be leading development of fragmentomic liquid biopsies for cancer!

Combining genome-wide cfDNA profiling with AI/ML methods, our aim is to create accessible testing that detects cancer sooner when it can be more readily treated. I'm especially excited to be broadening my scope into data science and clinical applications as we embark on partnerships to demonstrate the effectiveness of our technology. Feel free to reach out if you'd like to learn more! #cancer #liquidbiopsy #genomics #ai #cfDNA #productmanagement

Apr 23 · linkedin

Passing of a legend. Thomas Brock discovered the bacterium behind Taq Polymerase which is the enzyme and ‘P’ in PCR.

It’s the foundation of much in molecular biology including diagnostic tests for COVID-19, infectious diseases, oncology, and more. What a great contribution to science and society! 🧬

#molecularbiology #moleculartesting #covidtests #covidtesting #VisbyMedical

Adrian Chung, MBA, CA
Add to my network

Location

Seattle, Washington, United States